BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 29554204)

  • 1. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
    He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
    Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion.
    McKinney EF; Smith KG
    Curr Opin Immunol; 2016 Dec; 43():74-80. PubMed ID: 27744240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8
    Li J; He Y; Hao J; Ni L; Dong C
    Front Immunol; 2018; 9():2981. PubMed ID: 30619337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaustion-associated regulatory regions in CD8
    Mognol GP; Spreafico R; Wong V; Scott-Browne JP; Togher S; Hoffmann A; Hogan PG; Rao A; Trifari S
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2776-E2785. PubMed ID: 28283662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8
    Seo H; Chen J; González-Avalos E; Samaniego-Castruita D; Das A; Wang YH; López-Moyado IF; Georges RO; Zhang W; Onodera A; Wu CJ; Lu LF; Hogan PG; Bhandoola A; Rao A
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12410-12415. PubMed ID: 31152140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating CD8
    Kumar S; Singh SK; Rana B; Rana A
    Drug Discov Today; 2021 Apr; 26(4):951-967. PubMed ID: 33450394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
    Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
    Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression.
    Egilmez NK; Kilinc MO
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):399-405. PubMed ID: 20872283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral Tcf1
    Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
    Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-resident memory T cells in tumor immunity and immunotherapy.
    Okła K; Farber DL; Zou W
    J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33755718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
    Zhao Y; Shao Q; Peng G
    Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Huang Y; Jia A; Wang Y; Liu G
    Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory CD8
    Han J; Khatwani N; Searles TG; Turk MJ; Angeles CV
    Semin Immunol; 2020 Jun; 49():101435. PubMed ID: 33272898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.
    Hao L; Li S; Hu X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12543-12560. PubMed ID: 37423958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common gamma chain cytokines and CD8 T cells in cancer.
    Shourian M; Beltra JC; Bourdin B; Decaluwe H
    Semin Immunol; 2019 Apr; 42():101307. PubMed ID: 31604532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.